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Hemoglobin sickle cell disease in Brazil
We read with great interest the recent paper presented
by Lionnet et al.1 and we would like to briefly report our
experience with hemoglobin SC (HbSC) disease. Before
the institution of neonatal screening in Brazil, HbSC dis-
ease was considered a rare manifestation.2 After 2001,
however, the screening program had showed an unex-
pected high frequency of HbSC disease of 1:3,450.3-5
In our clinic, we have 94 children (median age 3 years,
range 1-17 years) and 29 adults (median age 35 years,
range 19-81 years) with HbSC disease. It is important to
point out that 67% of the patients were under ten years
of age. We presume that the toddler group had a better
follow up because they have been followed since they
were born. Otherwise, other patients came to our clinic
after a late diagnosis, and perhaps could have undergone
selection, and patients with more severe manifestations
did not have time to reach our service. 
Furthermore, the age distribution observed in our clinic
reflects the data from neonatal screening and is in agree-
ment with the point of view of Lionnet et al. that Hb SC
disease is not a mild form of sickle cell anemia.1
Regarding clinical manifestations in adult patients, we
observed a higher frequency of leg ulcer (3 of 29, 10.3%),
a similar frequency of osteonecrosis (4 of 29, 13.8%), and
a lower frequency of vasoocclusive crises, retinopathy
and priapism of 8 of 29 (27.6%), 6 of 29 (20.8%), 3 of 29
(10.3%), respectively. No patient had stroke. In addition,
we observed a high frequency of gallbladder (9 of 29,
31.0%).
The prevalence of a-thalassemia in our patients was
26.7%. We also accessed the bs haplotype of these
patients and observed a high frequency of Benin haplo-
type (51.7%) in a region where a large proportion of the
sickle cell anemia patients (61.7%) come from Bantu eth-
nic groups.6,7 This disparity in data obtained on SC
patients’ haplotype could be related to internal migratory
flow, since many individuals from Bahia (were Benin
haplotype prevails) come from the southeastern region.8
However, another possible interpretation could be a
modulatory action of Benin haplotype allowing these
patients to have a better survival than patients with other
bs haplotypes.
Our results reinforce the view that HbSC disease has
important comorbidities. In children, for example, we
observed 26.5% of acute chest syndrome, a manifesta-
tion associated with low HbF levels (Cabañas-Pedro AC et
al., manuscript in preparation).
We agree with Lionnet et al.1 that specific guidelines for
HbSC disease management are needed, but we would
like to highlight the importance of clarifying the role of
haplotype analysis in these patients. 
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